Supporting decisions about genomic newborn screening at scale in the digital age: the BabyScreen+ study

npj Genomic Medicine 2026 Open access

Read full text
Authors: Lilian Downie, Jade Caruana, Nathasha Kugenthiran, Anaita Kanga-Parabia, Erin Tutty, Yvonne Bombard, Marc Clausen, Sophie E. Bouffler, Clara Gaff, Alison Dalton Archibald, Sebastian Lunke, Zornitza Stark
DOI: 10.1038/s41525-026-00551-6
Cited by: 1
References: 29

Abstract

Digital platforms hold promise to scale implementation of population screening. We tailored the Genetics Adviser platform to provide education, decision support, consent, and result return in a genomic newborn screening (gNBS) study, BabyScreen + . Participants were surveyed and interviewed on the usability and value of Genetics Adviser. Genetics Adviser was used by 1048 participants and 1007 (96%) provided feedback. The majority (96%, n = 963) found the platform easy to navigate, with 85% (n = 851) spending

Fields of Study & Subjects

BRCA gene mutations in cancer Genomics and Rare Diseases Prenatal Screening and Diagnostics

Publication details

Journal / source
npj Genomic Medicine
Publisher
Springer Science and Business Media LLC
Volume
11
Issue
1
Publication date
14 February 2026
Language
EN